- Crystalys nets $130M more to push gout drug through late-stage tests<figure><div><img src="https://imgproxy.divecdn.com/THeKNpwt2ETxP7Nf-ec1mU-DtgG84p4ktQEqFznWC1c/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xODUxMTEwNjQucG5n.…BioPharma Dive · 2d ago↗ source
- Job dissatisfaction and health care access uncertainty grows in the U.S., new study findsWhat Hawaii's wildfires can teach the nation about health recovery, 4.5 million people disenrolled from SNAP, and more health newsSTAT · 2d ago↗ source
- 2026 IPO stock tracker: How newly public biotechs are performingBioSpace is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026.BioSpace